Loading…
CytoLyt® Fixation Significantly Inhibits MIB1 Immunoreactivity, whereas Alternative Ki67 Clone 30-9 is not Susceptible to the Inhibition: Critical Diagnostic Implications
CytoLyt® fixation substantially inhibits MIB1 immunoreactivity and may present a diagnostic pitfall in certain tumors, especially small cell carcinoma. The Ki67 30-9 clone shows adequate performance and we strongly recommend it for laboratories utilizing CytoLyt® collection media.
Saved in:
| Published in: | Cancer cytopathology 2019-08, Vol.127 (10), p.643-649 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 649 |
| container_issue | 10 |
| container_start_page | 643 |
| container_title | Cancer cytopathology |
| container_volume | 127 |
| creator | Buonocore, Darren J. Konno, Fumiko Jungbluth, Achim A. Frosina, Denise Fayad, Mariam Edelweiss, Marcia Lin, Oscar Rekhtman, Natasha |
| description | CytoLyt® fixation substantially inhibits MIB1 immunoreactivity and may present a diagnostic pitfall in certain tumors, especially small cell carcinoma. The Ki67 30-9 clone shows adequate performance and we strongly recommend it for laboratories utilizing CytoLyt® collection media. |
| doi_str_mv | 10.1002/cncy.22170 |
| format | article |
| fullrecord | <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8375359</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_8375359</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_83753593</originalsourceid><addsrcrecordid>eNqljU1OwzAQhS0EouVnwwnmALTYMW0SFkgQqKiAVVmwi1zjNoMcO4onhZwJiUNwMowESKxZvfdmnr7H2JHgY8F5cqKd7sdJIlK-xYYil6ej6VRm278-eRywvRCeORdZmohdNpBC5lmSiSF7K3rydz19vMMMXxWhd7DAtcMVauXI9jB3FS6RAtzPLwXM67pzvjVKE26Q-mN4qUyMAS4smdZFwsbALU5TKKx3BiQf5YABnCdYdEGbhnBpDZAHqswPPc6eQdFGo5WFK1Rr50MMca-x8fZVCAdsZ6VsMIffus_OZ9cPxc2o6Za1edLGUats2bRYq7YvvcLy78dhVa79psxkOpGTXP4b8An5W39I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CytoLyt® Fixation Significantly Inhibits MIB1 Immunoreactivity, whereas Alternative Ki67 Clone 30-9 is not Susceptible to the Inhibition: Critical Diagnostic Implications</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Buonocore, Darren J. ; Konno, Fumiko ; Jungbluth, Achim A. ; Frosina, Denise ; Fayad, Mariam ; Edelweiss, Marcia ; Lin, Oscar ; Rekhtman, Natasha</creator><creatorcontrib>Buonocore, Darren J. ; Konno, Fumiko ; Jungbluth, Achim A. ; Frosina, Denise ; Fayad, Mariam ; Edelweiss, Marcia ; Lin, Oscar ; Rekhtman, Natasha</creatorcontrib><description>CytoLyt® fixation substantially inhibits MIB1 immunoreactivity and may present a diagnostic pitfall in certain tumors, especially small cell carcinoma. The Ki67 30-9 clone shows adequate performance and we strongly recommend it for laboratories utilizing CytoLyt® collection media.</description><identifier>ISSN: 1934-662X</identifier><identifier>EISSN: 1934-6638</identifier><identifier>DOI: 10.1002/cncy.22170</identifier><identifier>PMID: 31398281</identifier><language>eng</language><ispartof>Cancer cytopathology, 2019-08, Vol.127 (10), p.643-649</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids></links><search><creatorcontrib>Buonocore, Darren J.</creatorcontrib><creatorcontrib>Konno, Fumiko</creatorcontrib><creatorcontrib>Jungbluth, Achim A.</creatorcontrib><creatorcontrib>Frosina, Denise</creatorcontrib><creatorcontrib>Fayad, Mariam</creatorcontrib><creatorcontrib>Edelweiss, Marcia</creatorcontrib><creatorcontrib>Lin, Oscar</creatorcontrib><creatorcontrib>Rekhtman, Natasha</creatorcontrib><title>CytoLyt® Fixation Significantly Inhibits MIB1 Immunoreactivity, whereas Alternative Ki67 Clone 30-9 is not Susceptible to the Inhibition: Critical Diagnostic Implications</title><title>Cancer cytopathology</title><description>CytoLyt® fixation substantially inhibits MIB1 immunoreactivity and may present a diagnostic pitfall in certain tumors, especially small cell carcinoma. The Ki67 30-9 clone shows adequate performance and we strongly recommend it for laboratories utilizing CytoLyt® collection media.</description><issn>1934-662X</issn><issn>1934-6638</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqljU1OwzAQhS0EouVnwwnmALTYMW0SFkgQqKiAVVmwi1zjNoMcO4onhZwJiUNwMowESKxZvfdmnr7H2JHgY8F5cqKd7sdJIlK-xYYil6ej6VRm278-eRywvRCeORdZmohdNpBC5lmSiSF7K3rydz19vMMMXxWhd7DAtcMVauXI9jB3FS6RAtzPLwXM67pzvjVKE26Q-mN4qUyMAS4smdZFwsbALU5TKKx3BiQf5YABnCdYdEGbhnBpDZAHqswPPc6eQdFGo5WFK1Rr50MMca-x8fZVCAdsZ6VsMIffus_OZ9cPxc2o6Za1edLGUats2bRYq7YvvcLy78dhVa79psxkOpGTXP4b8An5W39I</recordid><startdate>20190809</startdate><enddate>20190809</enddate><creator>Buonocore, Darren J.</creator><creator>Konno, Fumiko</creator><creator>Jungbluth, Achim A.</creator><creator>Frosina, Denise</creator><creator>Fayad, Mariam</creator><creator>Edelweiss, Marcia</creator><creator>Lin, Oscar</creator><creator>Rekhtman, Natasha</creator><scope>5PM</scope></search><sort><creationdate>20190809</creationdate><title>CytoLyt® Fixation Significantly Inhibits MIB1 Immunoreactivity, whereas Alternative Ki67 Clone 30-9 is not Susceptible to the Inhibition: Critical Diagnostic Implications</title><author>Buonocore, Darren J. ; Konno, Fumiko ; Jungbluth, Achim A. ; Frosina, Denise ; Fayad, Mariam ; Edelweiss, Marcia ; Lin, Oscar ; Rekhtman, Natasha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_83753593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Buonocore, Darren J.</creatorcontrib><creatorcontrib>Konno, Fumiko</creatorcontrib><creatorcontrib>Jungbluth, Achim A.</creatorcontrib><creatorcontrib>Frosina, Denise</creatorcontrib><creatorcontrib>Fayad, Mariam</creatorcontrib><creatorcontrib>Edelweiss, Marcia</creatorcontrib><creatorcontrib>Lin, Oscar</creatorcontrib><creatorcontrib>Rekhtman, Natasha</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer cytopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buonocore, Darren J.</au><au>Konno, Fumiko</au><au>Jungbluth, Achim A.</au><au>Frosina, Denise</au><au>Fayad, Mariam</au><au>Edelweiss, Marcia</au><au>Lin, Oscar</au><au>Rekhtman, Natasha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CytoLyt® Fixation Significantly Inhibits MIB1 Immunoreactivity, whereas Alternative Ki67 Clone 30-9 is not Susceptible to the Inhibition: Critical Diagnostic Implications</atitle><jtitle>Cancer cytopathology</jtitle><date>2019-08-09</date><risdate>2019</risdate><volume>127</volume><issue>10</issue><spage>643</spage><epage>649</epage><pages>643-649</pages><issn>1934-662X</issn><eissn>1934-6638</eissn><abstract>CytoLyt® fixation substantially inhibits MIB1 immunoreactivity and may present a diagnostic pitfall in certain tumors, especially small cell carcinoma. The Ki67 30-9 clone shows adequate performance and we strongly recommend it for laboratories utilizing CytoLyt® collection media.</abstract><pmid>31398281</pmid><doi>10.1002/cncy.22170</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1934-662X |
| ispartof | Cancer cytopathology, 2019-08, Vol.127 (10), p.643-649 |
| issn | 1934-662X 1934-6638 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8375359 |
| source | Wiley-Blackwell Read & Publish Collection |
| title | CytoLyt® Fixation Significantly Inhibits MIB1 Immunoreactivity, whereas Alternative Ki67 Clone 30-9 is not Susceptible to the Inhibition: Critical Diagnostic Implications |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T05%3A39%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CytoLyt%C2%AE%20Fixation%20Significantly%20Inhibits%20MIB1%20Immunoreactivity,%20whereas%20Alternative%20Ki67%20Clone%2030-9%20is%20not%20Susceptible%20to%20the%20Inhibition:%20Critical%20Diagnostic%20Implications&rft.jtitle=Cancer%20cytopathology&rft.au=Buonocore,%20Darren%20J.&rft.date=2019-08-09&rft.volume=127&rft.issue=10&rft.spage=643&rft.epage=649&rft.pages=643-649&rft.issn=1934-662X&rft.eissn=1934-6638&rft_id=info:doi/10.1002/cncy.22170&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_8375359%3C/pubmedcentral%3E%3Cgrp_id%3Ecdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_83753593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/31398281&rfr_iscdi=true |